Bax protein may influence the invasion of colorectal cancer

World Journal of Gastroenterology

Volumn 20, Issue 5, 2014, Pages 1305-1310

  Pryczynicz, Anna ^a   Gryko, Mariusz ^a   Niewiarowska, Katarzyna ^a   Cepowicz, Dariusz ^a   Ustymowicz, Marek ^a   Kemona, Andrzej ^a   Guzińska Ustymowicz, Katarzyna ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b BIALYSTOK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Bak; Bax; Bcl xL; Cancer cell infiltration; Colorectal cancer

Indexed keywords

PROTEIN BAK; PROTEIN BAX; PROTEIN BCL XL;

ADULT; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL EVALUATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MORBIDITY; PROTEIN EXPRESSION; TUMOR INVASION; TUMOR LOCALIZATION;

BAK; BAX; BCL-XL; CANCER CELL INFILTRATION; COLORECTAL CANCER;

BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM INVASIVENESS; TUMOR MARKERS, BIOLOGICAL;

EID: 84893102096     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i5.1305     Document Type: Article

References (22)

1. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 2003; 39: 615-647 [PMID: 12493639 DOI: 10.1016/S0161-5890(02)00252-3]
2. Bouillet P, Strasser A. BH3-only proteins - evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J Cell Sci 2002; 115: 1567-1574 [PMID: 11950875]
3. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000; 6: 513-519 [PMID: 10802706 DOI: 10.1038/74994]
4. Glinsky GV. Apoptosis in metastatic cancer cells. Crit Rev Oncol Hematol 1997; 25: 175-186 [PMID: 9177940 DOI: 10.1016/ S1040-8428(97)00234-5]
5. Holdenrieder S, Stieber P. Apoptotic markers in cancer. Clin Biochem 2004; 37: 605-617 [PMID: 15234242 DOI: 10.1016/ j.clinbiochem.2004.05.003]
6. Huerta S, Goulet EJ, Livingston EH. Colon cancer and apoptosis. Am J Surg 2006; 191: 517-526 [PMID: 16531147 DOI: 10.1016/j.amjsurg.2005.11.009]
7. AJCC Cancer Staging Manual, 7th ed. Available from: URL: http://cancerstaging.org/Pages/default.aspx
8. Jass JR. Lymphocytic infiltration and survival in rectal cancer. J Clin Pathol 1986; 39: 585-589 [PMID: 3722412 DOI: 10.1136/jcp.39.6.585]
9. Guzińska-Ustymowicz K. Aggressive and non-aggressive tumor budding in colorectal cancers. In: Tumor budding in colorectal cancer. New York: Nova Science Publishers, Inc., 2006: 105-116
10. Morodomi T, Isomoto H, Shirouzu K, Kakegawa K, Irie K, Morimatsu M. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 1989; 63: 539-543 [PMID: 2912530]
11. Sturm I, Köhne CH, Wolff G, Petrowsky H, Hillebrand T, Hauptmann S, Lorenz M, Dörken B, Daniel PT. Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases. J Clin Oncol 1999; 17: 1364-1374 [PMID: 10334520]
12. Partik G, Kahl-Rainer P, Sedivy R, Ellinger A, Bursch W, Marian B. Apoptosis in human colorectal tumours: ultrastructure and quantitative studies on tissue localization and association with bak expression. Virchows Arch 1998; 432: 415-426 [PMID: 9645440 DOI: 10.1007/s004280050185]
13. Jansson A, Sun XF. Bax expression decreases significantly from primary tumor to metastasis in colorectal cancer. J Clin Oncol 2002; 20: 811-816 [PMID: 11821465 DOI: 10.1200/ JCO.20.3.811]
14. Alper M, Cukur S, Belenli O, Suna M. Evaluation of the immunohistochemical stain patterns of survivin, Bak and Bag-1 in colorectal cancers and comparison with polyps situated in the colon. Hepatogastroenterology 2008; 55: 1269-1273 [PMID: 18795671]
15. Badvie S, Hanna-Morris A, Andreyev HJ, Cohen P, Saini S, Allen-Mersh TG. A "field change" of inhibited apoptosis occurs in colorectal mucosa adjacent to colorectal adenocarcinoma. J Clin Pathol 2006; 59: 942-946 [PMID: 16679352 DOI: 10.1136/jcp.2005.033431]
16. Maurer CA, Friess H, Bühler SS, Wahl BR, Graber H, Zimmermann A, Büchler MW. Apoptosis inhibiting factor BclxL might be the crucial member of the Bcl-2 gene family in colorectal cancer. Dig Dis Sci 1998; 43: 2641-2648 [PMID: 9881495 DOI: 10.1023/A:1026695025990]
17. Koornstra JJ, de Jong S, Hollema H, de Vries EG, Kleibeuker JH. Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature. Crit Rev Oncol Hematol 2003; 45: 37-53 [PMID: 12482571 DOI: 10.1016/S1040-8428(01)00228-1]
18. Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996; 56: 2422-2427 [PMID: 8625322]
19. Tsamandas AC, Kardamakis D, Petsas T, Zolota V, Vassiliou V, Matatsoris T, Kalofonos H, Vagianos CE, Scopa CD. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome. In Vivo 2007; 21: 113-118 [PMID: 17354623]
20. Zhang YL, Pang LQ, Wu Y, Wang XY, Wang CQ, Fan Y. Significance of Bcl-xL in human colon carcinoma. World J Gastroenterol 2008; 14: 3069-3073 [PMID: 18494061 DOI: 10.3748/wjg.14.3069]
21. Ogura E, Senzaki H, Yamamoto D, Yoshida R, Takada H, Hioki K, Tsubura A. Prognostic significance of Bcl-2, Bcl-xL/ S, Bax and Bak expressions in colorectal carcinomas. Oncol Rep 1999; 6: 365-369 [PMID: 10023006]
22. Karamitopoulou E, Lugli A, Panayiotides I, Karakitsos P, Peros G, Rallis G, Patsouris ES, Terracciano L, Zlobec I. Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer. Histopathology 2010; 57: 233-243 [PMID: 20716165 DOI: 10.1111/j.1365-2559.2010.03615.x]